Literature DB >> 197361

Neurotransmitter receptor alterations in Parkinson's disease.

T D Reisine, J Z Fields, H I Yamamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 197361     DOI： 10.1016/0024-3205(77)90514-8

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  27 in total

1.  Pharmacokinetic and pharmacodynamic changes during the first four years of levodopa treatment in Parkinson's disease.

Authors:  Phylinda L S Chan; John G Nutt; Nicholas H G Holford
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-08       Impact factor: 2.745

2.  Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.

Authors:  Jo Ann V Antenor-Dorsey; Joanne Markham; Stephen M Moerlein; Tom O Videen; Joel S Perlmutter
Journal:  Nucl Med Biol       Date:  2008-04       Impact factor: 2.408

3.  The effects of L-dopa on the activity of methionine adenosyltransferase: relevance to L-dopa therapy and tolerance.

Authors:  R Benson; B Crowell; B Hill; K Doonquah; C Charlton
Journal:  Neurochem Res       Date:  1993-03       Impact factor: 3.996

4.  Dopamine-sensitive adenylate cyclase activity in the striatum in Parkinson's disease.

Authors:  M Shibuya
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

5.  Dopamine receptors in the Parkinsonian brain.

Authors:  U K Rinne; P Lönnberg; V Koskinen
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

6.  Asymmetrical lateral ventricular enlargement in Parkinson's disease.

Authors:  M M Lewis; A B Smith; M Styner; H Gu; R Poole; H Zhu; Y Li; X Barbero; S Gouttard; M J McKeown; R B Mailman; X Huang
Journal:  Eur J Neurol       Date:  2009-04       Impact factor: 6.089

7.  Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.

Authors:  R Miller
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

8.  The effects of acute levodopa withdrawal on motor performance and dopaminergic receptor sensitivity in patients with Parkinson's disease.

Authors:  N Turjanski; W Fernandez; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-07       Impact factor: 10.154

9.  Treatment of Parkinson's disease: problems with a progressing disease.

Authors:  U K Rinne
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

Review 10.  The hypothalamus in Parkinson disease.

Authors:  R Sandyk; R P Iacono; C R Bamford
Journal:  Ital J Neurol Sci       Date:  1987-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.